COLYTE (MEDA Pharmaceuticals)


Welcome to the PulseAid listing for the COLYTE drug offered from MEDA Pharmaceuticals. This Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MEDA Pharmaceuticals
NON-PROPRIETARY NAME: peg-3350 and electrolytes
SUBSTANCE NAME: POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
ROUTE: NASOGASTRIC
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-08-05
END MARKETING DATE: 0000-00-00


COLYTE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCOLYTE from MEDA Pharmaceuticals
LABELER NAME: MEDA Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 240; 5.84; 2.98; 6.72; 22.72(g/4L; g/4L; g/4L; g/4L; g/4L)
START MARKETING DATE: 2014-08-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0037-6820_ad34d2e0-1e98-11e4-8c21-0800200c9a66
PRODUCT NDC: 0037-6820
APPLICATION NUMBER: NDA018983

Other POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alaven Pharmaceutical LLCColyte
Kremers Urban Pharmaceuticals Inc.PEG-3350 and Electrolytes
MEDA PharmaceuticalsCOLYTE